Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Antibiotics are known to cause adverse reactions, but multiple organ involvement associated with nonspecific symptoms can lead to a delay in diagnosis. A definitive correlation between each toxin and its effects is difficult to establish due to concomitant potential toxins in the circulation. This article highlights an uncommon case of concomitant nitrofurantoin-induced autoimmune hepatitis and lung fibrosis that fulfills the definitive clinical criteria for diagnosis, presenting histological, imagiological, and immunological evidence of nitrofurantoin-induced toxicity. It occurred in a 68-year-old woman with extended nitrofurantoin intake for urinary tract infection prophylaxis who presented with progressive exercise dyspnea and jaundice. Similar published cases are also reviewed in this article.

Cite

CITATION STYLE

APA

De Matos, A. C., MacEdo, C. P., Mendes, P. A., Cipriano, M. A., Paiva, A., & Simão, A. (2022). Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease. GE Portuguese Journal of Gastroenterology, 29(4), 273–279. https://doi.org/10.1159/000516940

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free